13Sep 2021
Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer

Telomerase reverse transcriptase mutation and the p53 pathway in T1 urinary bladder cancer

We aimed to study the telomerase reverse transcriptase (TERT) mutation and the p53 pathway in T1 urinary bladder cancer (UBC). In stage T1 UBC, the combination of the TERT mutation and the p53 mutation was associated with tumour progression. A protective effect of the TERT promotor mutation against tumour progression induced by the p53 mutation and subsequent p53 accumulation in tumour cells might be possible, but further investigations are necessary.

  • #urology

Like

Save

Share